Mr Simon Roberts > McDermott Will & Emery LLP > New York, United States > Lawyer Profile
McDermott Will & Emery LLP Offices
340 MADISON AVENUE
NEW YORK, NY 10173-1922
NEW YORK
United States
- Firm Profile
- Go to...
Mr Simon Roberts
Work Department
IP Litigation
Position
Simon Roberts focuses his practice on patent litigation in the life sciences and biotechnology sectors. He has nearly 30 years of experience practicing law in both the US and Europe. Simon leverages his background in chemistry to translate complex technical issues into relatable terms for clients.
Simon has in-depth experience and knowledge in Hatch-Waxman related litigations involving small molecules as well as other pharma-related patent matters including those involving large molecule pharmaceuticals. With a proven track record in high-stakes litigation matters, Simon represents clients before the federal courts as well as the United States Patent and Trademark Office (USPTO) in contested proceedings including IPRs and PGRs.
Read full biography: https://www.mwe.com/people/roberts-simon/
Lawyer Rankings
United States > Intellectual property > Patents: litigation (full coverage)
Fielding a team of ‘experts in multiple patent lawsuits in pharmaceutical field‘, McDermott Will & Emery LLP represents global and domestic clients in patent litigation across industry sectors, with particular emphasis on the life sciences space. William Gaede in San Francisco leads the global intellectual property practice and acts for biotech, pharma, and medical device companies. Patent litigator Douglas Carsten in Orange County is a life sciences expert, Boston-based IP attorney Sarah Columbia works across the pharma and tech sectors, and Michael Chu in Chicago has a broad IP practice. The group also includes IP litigators Thomas Steindler in Washington DC, Shane Nichols in Atlanta, and Kevin Meek in Austin, and New-York based lawyer Simon Roberts, who handles patent infringement cases for major pharma companies.
Lawyer Rankings
Top Tier Firm Rankings
- Media, technology and telecoms > Technology transactions
- Healthcare > Health insurers
- Healthcare > Life sciences
- Media, technology and telecoms > Outsourcing
- Healthcare > Service providers
- Tax > US taxes: contentious
- Tax > US taxes: non-contentious
Firm Rankings
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy regulation: electric power
- Tax > Financial products
- Labor and employment > Immigration
- Tax > International tax
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Energy > Renewable/alternative power
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Labor and employment > Workplace and employment counseling
- Insurance > Advice to insurers
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > ERISA litigation
- Dispute resolution > General commercial disputes
- Insurance > Insurance: non-contentious
- Labor and employment > Labor and employment disputes (including collective actions)
- Labor and employment > Labor-management relations
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Real estate > Real estate finance
- Finance > Capital markets: equity offerings
- Antitrust > Cartel
- Antitrust > Civil litigation/class actions: defense
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Government > Government contracts
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- Finance > Structured finance: derivatives and structured products
- International trade and national security > Trade remedies and trade policy
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > International arbitration
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Real estate > Real estate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Finance > Fintech